{"id":1739,"date":"2023-08-30T11:30:11","date_gmt":"2023-08-30T09:30:11","guid":{"rendered":"https:\/\/dextechmedical.com\/?p=1739"},"modified":"2023-08-30T11:00:27","modified_gmt":"2023-08-30T09:00:27","slug":"year-end-report-july-1-2021-june-30-2022-2","status":"publish","type":"post","link":"https:\/\/dextechmedical.com\/en\/year-end-report-july-1-2021-june-30-2022-2\/","title":{"rendered":"Year-end report July 1, 2021 &#8211; June 30, 2022"},"content":{"rendered":"<div class=\"page\" title=\"Page 1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><em>By &#8220;Company&#8221; or &#8220;DexTech&#8221; is meant DexTech Medical AB with organization number 556664-6203.<\/em><\/p>\n<p><strong>Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30)<\/strong><\/p>\n<ul>\n<li>Net sales amounted to MSEK 0,0 (0,0)<\/li>\n<li>Operating profit\/loss amounted to MSEK -1,3 (-2,1)<\/li>\n<li>Earnings per share* SEK -0.06 (-0.11)<\/li>\n<\/ul>\n<p>* Before and after dilution. Earnings per share: Profit for the period divided by the average number of shares 18,485,857. For the comparison period, the average number of shares was 18,485,857. Amounts in brackets refer to the corresponding period last year.<\/p>\n<p><strong>Summary of the financial year (2021-07-01 \u2013 2022-06-30)<\/strong><\/p>\n<ul>\n<li>Net sales amounted to MSEK 0,0 (0,0)<\/li>\n<li>Operating profit\/loss amounted to MSEK -4,9 (-5,3)<\/li>\n<li>Earnings per share* SEK -0.25 (-0.31)<\/li>\n<li>Cash and cash equivalents at the end of the period amounted to MSEK 25,2 (35,5)<\/li>\n<\/ul>\n<p>* Before and after dilution. Earnings per share: Profit for the period divided by the average number of shares 18,485,857. For the comparison period, the average number of shares was 16,790,364. Amounts in brackets refer to the corresponding period last year.<\/p>\n<p><strong>CEO&#8217;s comment<\/strong><\/p>\n<p>The company&#8217;s phase 1 study regarding OsteoDex&#8217;s treatment of multiple myeloma is underway and patient recruitment is ongoing.<\/p>\n<p>The principal investigator (PI) is Dr. Katarina Uttervall, MD, PhD, Department of Hematology\/HERM, Karolinska University Hospital, Huddinge. Biomarkers are analysed at the Central Laboratory, Karolinska University Hospital, NKS, Solna. Patients with relapsed\/treatment-resistant disease and who have received 1\u20133 previous lines of treatment are included. The primary objective is to confirm safety and tolerability and, as a secondary objective, to determine any treatment response. Documentation of quality of life will also be done (QoL scores).<\/p>\n<p>Study material, GMP manufactured OsteoDex, is produced by Biovian OY, Turku, Finland and is delivered to the respective hospitals. We look forward to conducting this study.<\/p>\n<p>Anders R Holmberg<br \/>\nCEO<\/p>\n<p><a href=\"https:\/\/dextechmedical.com\/wp-content\/uploads\/Dextech-Year-end-report-July-2022-June-2023.pdf\">Dextech &#8211; Year-end report July 2022 &#8211; June 2023<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>By &#8220;Company&#8221; or &#8220;DexTech&#8221; is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30) Net sales amounted to MSEK 0,0 (0,0) Operating profit\/loss [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1739","post","type-post","status-publish","format-standard","hentry","category-okategoriserade-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Year-end report July 1, 2021 - June 30, 2022 | DexTech<\/title>\n<meta name=\"description\" content=\"By &quot;Company&quot; or &quot;DexTech&quot; is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30) Net\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dextechmedical.com\/?p=1735\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Year-end report July 1, 2021 - June 30, 2022 | DexTech\" \/>\n<meta property=\"og:description\" content=\"By &quot;Company&quot; or &quot;DexTech&quot; is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30) Net\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dextechmedical.com\/?p=1735\" \/>\n<meta property=\"og:site_name\" content=\"DexTech\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T09:30:11+00:00\" \/>\n<meta name=\"author\" content=\"G\u00f6sta Lundgren\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"G\u00f6sta Lundgren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dextechmedical.com\/?p=1735\",\"url\":\"https:\/\/dextechmedical.com\/?p=1735\",\"name\":\"Year-end report July 1, 2021 - June 30, 2022 | DexTech\",\"isPartOf\":{\"@id\":\"https:\/\/dextechmedical.com\/#website\"},\"datePublished\":\"2023-08-30T09:30:11+00:00\",\"author\":{\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c\"},\"description\":\"By \\\"Company\\\" or \\\"DexTech\\\" is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30) Net\",\"breadcrumb\":{\"@id\":\"https:\/\/dextechmedical.com\/?p=1735#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dextechmedical.com\/?p=1735\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dextechmedical.com\/?p=1735#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dextechmedical.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Year-end report July 1, 2021 &#8211; June 30, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dextechmedical.com\/#website\",\"url\":\"https:\/\/dextechmedical.com\/\",\"name\":\"DexTech\",\"description\":\"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dextechmedical.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c\",\"name\":\"G\u00f6sta Lundgren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g\",\"caption\":\"G\u00f6sta Lundgren\"},\"sameAs\":[\"https:\/\/dextechmedical.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Year-end report July 1, 2021 - June 30, 2022 | DexTech","description":"By \"Company\" or \"DexTech\" is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30) Net","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dextechmedical.com\/?p=1735","og_locale":"en_US","og_type":"article","og_title":"Year-end report July 1, 2021 - June 30, 2022 | DexTech","og_description":"By \"Company\" or \"DexTech\" is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30) Net","og_url":"https:\/\/dextechmedical.com\/?p=1735","og_site_name":"DexTech","article_published_time":"2023-08-30T09:30:11+00:00","author":"G\u00f6sta Lundgren","twitter_misc":{"Written by":"G\u00f6sta Lundgren","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dextechmedical.com\/?p=1735","url":"https:\/\/dextechmedical.com\/?p=1735","name":"Year-end report July 1, 2021 - June 30, 2022 | DexTech","isPartOf":{"@id":"https:\/\/dextechmedical.com\/#website"},"datePublished":"2023-08-30T09:30:11+00:00","author":{"@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c"},"description":"By \"Company\" or \"DexTech\" is meant DexTech Medical AB with organization number 556664-6203. Summary of the fourth quarter (2022-04-01 \u2013 2022-06-30) Net","breadcrumb":{"@id":"https:\/\/dextechmedical.com\/?p=1735#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dextechmedical.com\/?p=1735"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dextechmedical.com\/?p=1735#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dextechmedical.com\/en\/"},{"@type":"ListItem","position":2,"name":"Year-end report July 1, 2021 &#8211; June 30, 2022"}]},{"@type":"WebSite","@id":"https:\/\/dextechmedical.com\/#website","url":"https:\/\/dextechmedical.com\/","name":"DexTech","description":"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dextechmedical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c","name":"G\u00f6sta Lundgren","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g","caption":"G\u00f6sta Lundgren"},"sameAs":["https:\/\/dextechmedical.com"]}]}},"_links":{"self":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/1739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/comments?post=1739"}],"version-history":[{"count":1,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/1739\/revisions"}],"predecessor-version":[{"id":1742,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/1739\/revisions\/1742"}],"wp:attachment":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/media?parent=1739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/categories?post=1739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/tags?post=1739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}